News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Coordinated attacks struck Mali military sites and northern towns, with jihadist and Tuareg groups claiming responsibility and the army reporting heavy assailant casualties.
  • Mizuho analyst says AI-driven CPU demand will boost DRAM and HBM sales, making several memory stocks attractive on valuation grounds.
  • MOEX Russia index finished flat as gains in steel and oil offset losses in metals and airlines, while the ruble strengthened.
  • Former Fed governor Kevin Warsh favored Trimmed PCE at a hearing, reviving debate over Fed signaling and rate-cut flexibility.
  • KB Securities said Warsh's comments sounded hawkish even though Trimmed PCE can serve as a dovish trend-confirmation measure.

Latest Articles

Vishay Intertechnology Automotive Grade Photovoltaic MOSFET Driver Boosts Reliability and Lowers Costs in High Voltage Systems

Vishay Intertechnology Automotive Grade Photovoltaic MOSFET Driver Boosts Reliability and Lowers Costs in High Voltage Systems

Vishay Intertechnology, Inc. introduced the VODA1275, an automotive-grade photovoltaic MOSFET driver featuring industry-leading performance with faster turn-on times, reinforced isolation, and suitability for 800 V+ battery systems. The new device simplifies EV and HEV designs, reduces costs, and increases reliability by enabling single-device MOSF…

Aura Reports Updated Mineral Reserves and Mineral Resources For The Year-Ended 2025, Highlighting year of Significant Growth in Mineral Reserve and Resource Portfolio

Aura Reports Updated Mineral Reserves and Mineral Resources For The Year-Ended 2025, Highlighting year of Significant Growth in Mineral Reserve and Resource Portfolio

Aura Minerals Inc. updated its mineral reserves and resources for 2025, highlighting substantial growth driven by organic exploration success and strategic acquisitions such as the MSG Project and Era Dorada. The company reported increased proven and probable reserves of 7.22 million gold equivalent ounces (GEO), along with significant increases in…

Parsons Awarded Project Management Consultant Contract for Al Ittihad Sports Village in Saudi Arabia

Parsons Awarded Project Management Consultant Contract for Al Ittihad Sports Village in Saudi Arabia

Parsons Corporation has been awarded the project management consultant contract for the Al Ittihad Sports Village in Jeddah, Saudi Arabia. This project, connected to the country's Quality of Life Program under Saudi Vision 2030, includes development of sports facilities adhering to FIFA standards. Parsons leverages its extensive experience in sport…

Brown & Brown, Inc. named to Great Place To Work 2026 Best Workplaces in Canada and 2026 Best Workplaces with Most Trusted Executive Team Lists

Brown & Brown, Inc. named to Great Place To Work 2026 Best Workplaces in Canada and 2026 Best Workplaces with Most Trusted Executive Team Lists

Brown & Brown, Inc., a leading insurance brokerage firm listed on the NYSE as BRO, has been named to the 2026 Best Workplaces in Canada and the Best Workplaces with Most Trusted Executive Teams lists by Great Place To Work. This recognition highlights the company's strong workplace culture, employee trust, and leadership integrity, underscoring its…

Cespira’s Hydrogen HPDI™ Fuel System Now in On-Road Testing

Cespira’s Hydrogen HPDI™ Fuel System Now in On-Road Testing

Westport Fuel Systems Inc., through its joint venture Cespira, announced that its hydrogen HPDI fuel system technology is now being tested on-road by Volvo heavy-duty trucks powered by hydrogen. The technology leverages proven LNG HPDI systems, aiming to deliver nearly zero carbon emissions while maintaining existing engine architectures. Volvo pla…

Churchill Downs Incorporated Statement Regarding United States District Court Victory in Churchill Downs Inc. v. Horseracing Integrity and Safety Authority

Churchill Downs Incorporated Statement Regarding United States District Court Victory in Churchill Downs Inc. v. Horseracing Integrity and Safety Authority

Churchill Downs Incorporated announced a significant legal victory as the United States District Court ruled that the Horseracing Integrity and Safety Authority's fee methodology is arbitrary, capricious, and unlawful. This ruling challenges the authority's fiscal practices and may impact regulatory fee collections in the horse racing industry. Chu…

Whitestone REIT Adds Premier Tenant at BLVD Place, Signs Agreement for Parkhill’s Houston Headquarters

Whitestone REIT Adds Premier Tenant at BLVD Place, Signs Agreement for Parkhill’s Houston Headquarters

Whitestone REIT (NYSE: WSR) announced the signing of a 5,800-square-foot lease with architecture and engineering firm Parkhill at its premier BLVD Place mixed-use center in Houston's Uptown District. This lease underscores the strong demand for modern office space in a vibrant, amenity-rich environment. Whitestone's strategic repositioning of BLVD …

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Kala Bio Inc. has appointed Dr. Saeid Babaei as Senior Scientific Advisor to leverage AI and precision analytics in reassessing its clinical and molecular assets, particularly its proprietary MSC Secretome platform. This strategic move aims to unlock additional value by exploring amended indications and future development pathways including partner…

Westport Announces Issuance of Management Cease Trade Order

Westport Announces Issuance of Management Cease Trade Order

Westport Fuel Systems Inc. announced that the British Columbia Securities Commission has issued a temporary management cease trade order (MCTO) restricting trading by the CEO and CFO due to a cybersecurity incident which delayed the company's filing of its annual financial statements and related disclosures. The company is actively investigating th…

JD.com Announces Pricing of CNY10 Billion CNY-denominated Senior Notes

JD.com Announces Pricing of CNY10 Billion CNY-denominated Senior Notes

JD.com, a leading supply chain-based technology and service provider, announced the pricing of CNY10 billion aggregate principal amount of CNY-denominated senior unsecured notes via offshore transactions under Regulation S. The offering consists of CNY7.5 billion of 2.05% notes due 2031 and CNY2.5 billion of 2.75% notes due 2036. Proceeds will be u…

Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease

Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease

Ocugen, Inc. announced the early completion of dosing in its Phase 2/3 GARDian3 clinical trial for OCU410ST, a potential first-in-class modifier gene therapy for Stargardt disease. The trial enrolled 63 patients and aims to evaluate efficacy and safety in slowing the progression of this inherited retinal disorder. Interim data is expected in Q3 202…

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

Pasithea Therapeutics announced that the FDA has granted Fast Track designation to PAS-004, its next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (PN). This designation facilitates more frequent communication with the FDA, rolling review processes, and may enable accele…

Apollomics Inc. Announces $2.0 Million Bridge Financing

Apollomics Inc. Announces $2.0 Million Bridge Financing

Apollomics Inc., a clinical-stage biopharmaceutical company focused on oncology therapies, announced $2 million unsecured convertible promissory note financing from its CEO. The funds will support clinical development and corporate operations, with conversion linked to a future equity financing event. The financing terms were approved by the indepe…

NewGen Filed 2025 Annual Report on Form 20-F

NewGen Filed 2025 Annual Report on Form 20-F

NewGenIVF Group Limited announced the filing of its 2025 annual report on Form 20-F with the SEC. The company operates a diversified business spanning real estate development in the UAE, digital asset and DeFi solutions, and reproductive health services in Asia. The report highlights strategic initiatives across these sectors and discloses associat…

B2Gold Announces Renewal of Normal Course Issuer Bid

B2Gold Announces Renewal of Normal Course Issuer Bid

B2Gold Corp. has announced the renewal of its normal course issuer bid (NCIB), allowing the company to repurchase up to 132.7 million shares, equivalent to 10% of its public float, over the next 12 months. This move aligns with B2Gold's strategy to return value to shareholders and reflects management's belief that the shares may be undervalued. Sha…

Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions

Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions

Axsome Therapeutics has acquired exclusive global rights to balipodect (TAK-063), a selective PDE10A inhibitor from Takeda. The company plans to develop balipodect for schizophrenia and Tourette syndrome, initiating Phase 3 trial-enabling activities for schizophrenia in 2026. Balipodect represents a potential first-in-class mechanism targeting neur…

Eldorado Gold Reminds Shareholders to Vote FOR the Share Issuance Resolution and Foran Mining Reminds Securityholders to Vote FOR the Arrangement Resolution

Eldorado Gold Reminds Shareholders to Vote FOR the Share Issuance Resolution and Foran Mining Reminds Securityholders to Vote FOR the Arrangement Resolution

Eldorado Gold Corporation and Foran Mining Corporation announced upcoming shareholder meetings for approval of a proposed plan of arrangement wherein Eldorado will acquire Foran, making it a wholly-owned subsidiary. The combined entity aims to leverage Eldorado's financial strength and operational platform with Foran's copper growth projects, targe…

Lightbridge Receives Notice of Allowance on New U.S. Patent for its Metallic Fuel Assemblies for CANDU Reactors

Lightbridge Receives Notice of Allowance on New U.S. Patent for its Metallic Fuel Assemblies for CANDU Reactors

Lightbridge Corporation announced receiving a Notice of Allowance from the USPTO for a new U.S. patent covering its advanced spirally twisted, multi-lobed metallic fuel assemblies designed for pressurized heavy-water reactors including CANDU-type designs. This strengthens their intellectual property portfolio for their advanced nuclear fuel technol…

BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting

BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting

BioXcel Therapeutics announced that the FDA has accepted its supplemental New Drug Application for IGALMI® to be used in the at-home setting to acutely treat agitation associated with bipolar disorders or schizophrenia. The FDA set a PDUFA action date of November 14, 2026. This approval could introduce the first FDA-approved at-home treatment for a…